首页> 外文期刊>Journal of Applied Oral Science >In vitro and in vivo evaluations of glass-ionomer cement containing chlorhexidine for Atraumatic Restorative Treatment
【24h】

In vitro and in vivo evaluations of glass-ionomer cement containing chlorhexidine for Atraumatic Restorative Treatment

机译:含氯己定的玻璃离聚物水泥在无创修复中的体外和体内评价

获取原文
获取外文期刊封面目录资料

摘要

Abstract Objectives: Addition of chlorhexidine has enhanced the antimicrobial effect of glass ionomer cement (GIC) indicated to Atraumatic Restorative Treatment (ART); however, the impact of this mixture on the properties of these materials and on the longevity of restorations must be investigated. The aim of this study was to evaluate the effects of incorporating chlorhexidine (CHX) in the in vitro biological and chemical-mechanical properties of GIC and in vivo clinical/ microbiological follow-up of the ART with GIC containing or not CHX. Material and Methods: For in vitro studies, groups were divided into GIC, GIC with 1.25% CHX, and GIC with 2.5% CHX. Antimicrobial activity of GIC was analyzed using agar diffusion and anti-biofilm assays. Cytotoxic effects, compressive tensile strength, microhardness and fluoride (F) release were also evaluated. A randomized controlled trial was conducted on 36 children that received ART either with GIC or GIC with CHX. Saliva and biofilm were collected for mutans streptococci (MS) counts and the survival rate of restorations was checked after 7 days, 3 months and one year after ART. ANOVA/Tukey or Kruskal-Wallis/ Mann-Whitney tests were performed for in vitro tests and in vivo microbiological analysis. The Kaplan-Meier method and Log rank tests were applied to estimate survival percentages of restorations (p<0.05). Results: Incorporation of 1.25% and 2.5% CHX improved the antimicrobial/anti-biofilm activity of GIC, without affecting F release and mechanical characteristics, but 2.5% CHX was cytotoxic. Survival rate of restorations using GIC with 1.25% CHX was similar to GIC. A significant reduction of MS levels was observed for KM+CHX group in children saliva and biofilm 7 days after treatment. Conclusions: The incorporation of 1.25% CHX increased the in vitro antimicrobial activity, without changing chemical-mechanical properties of GIC and odontoblast-like cell viability. This combination improved the in vivo short-term microbiological effect without affecting clinical performance of ART restorations.
机译:摘要目的:氯己定的添加增强了玻璃离子水门汀(GIC)在无损伤修复治疗(ART)中的抗菌作用;但是,必须研究这种混合物对这些材料的性能以及修复体寿命的影响。这项研究的目的是评估将洗必泰(CHX)掺入GIC的体外生物学和化学力学性质以及ART与含或不含CHX的GIC的体内临床/微生物随访中的作用。材料和方法:为了进行体外研究,将组分为GIC,CHIC为1.25%的GIC和CHX为2.5%的GIC。使用琼脂扩散和抗生物膜测定法分析了GIC的抗菌活性。还评估了细胞毒性作用,抗压拉伸强度,显微硬度和氟化物(F)的释放。对36名接受GIC或ART联合CHX的儿童进行了一项随机对照试验。收集唾液和生物膜进行变形链球菌(MS)计数,并在ART后7天,3个月和一年后检查修复体的存活率。进行ANOVA / Tukey或Kruskal-Wallis / Mann-Whitney测试以进行体外测试和体内微生物学分析。应用Kaplan-Meier方法和Log rank检验来估计修复体的存活百分比(p <0.05)。结果:掺入1.25%和2.5%的CHX可以改善GIC的抗菌/抗生物膜活性,而不会影响F的释放和机械特性,但是2.5%的CHX具有细胞毒性。使用具有1.25%CHX的GIC的修复体存活率与GIC相似。治疗后7天,儿童唾液和生物膜中KM + CHX组的MS水平显着降低。结论:1.25%CHX的加入增加了体外抗菌活性,而没有改变GIC的化学机械性能和成牙本质细胞样细胞活力。该组合改善了体内短期微生物学作用,而不影响ART修复体的临床性能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号